healthcare professional
RITI®, a test that helps with the prescription of biotherapies in patients with autoimmune diseases
RITI® is the first test that helps with prescribing suitable biotherapies according to the patients’ biology. The RITI® test provides an efficacy score for each biotherapy depending on the biological profile of the patient. Through RITI®, you have all of the scientific, biological, and pharmacological information about your patient. RITI® is an innovative tool for optimizing the therapeutic strategy to be followed.
The goal is remission
The RITI® test gives you access to a personalized report. This report contains precise biological information and generates an efficacy score for each biotherapy depending on your patient’s immune dysregulation.
How does the
RITI® innovation work?
Blood
sample
A blood sample is taken from the patient.
Messenger RNA sequencing
Receipt of the patient’s blood sample by the genomic platform, which performs the messenger RNA sequencing.
Analyses and calculations
The patient’s messenger RNA signature is determined and then compared with the Therapeutic Efficacy Profile database. The mYXPression algorithm then calculates the Therapeutic Efficacy Score for each biotherapy.
The report is edited
The diseases treated
by RITI®
- RITI® RA for rheumatoid arthritis is CE marked.
- Ongoing clinical trial including 234 patients and 12 university or general hospitals in France. Goal: To supplement the clinical evidence for the efficacy of RITI® RA.
- Six biotherapies have already been included in RITI® RA. Other biotherapies will gradually be added.
Other diseases will be treated
by RITI® in the future
Rheumatoid arthritis
Crohn's disease
Lupus
contact us : info@myxpression.com